Evidence map›Paper›PMID 25035423›Full record

RevieweLife2014

Concerning RNA-guided gene drives for the alteration of wild populations.

Kevin M Esvelt, Andrea L Smidler, Flaminia Catteruccia, George M Church

Open access · goldAbstract readReview
In one paragraph

Review in eLife, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 342 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
342citing papers in PubMed, 1 pooled it
30.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

342 citing papers in PubMed, 1 synthesis or guideline pooled it, 897 citations in OpenAlex.

  1. The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Pooled it
  2. Article
  3. Article
  4. Efficacy of an attractive lethal ovitrap to reduce populations ofbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Climate-driven invasion ofOne health (Amsterdam, Netherlands) · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

282 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kevin M EsveltSynthetic Biology Platform, Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, United States.ORCID 0000-0001-8797-3945
Andrea L SmidlerSynthetic Biology Platform, Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, United States.ORCID 0000-0002-3281-1161
Flaminia CatterucciaDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, United States.
George M ChurchSynthetic Biology Platform, Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, Boston, United States.
Boston University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene drives may be capable of addressing ecological problems by altering entire populations of wild organisms, but their use has remained largely theoretical due to technical constraints. Here we consider the potential for RNA-guided gene drives based on the CRISPR nuclease Cas9 to serve as a general method for spreading altered traits through wild populations over many generations. We detail likely capabilities, discuss limitations, and provide novel precautionary strategies to control the spread of gene drives and reverse genomic changes. The ability to edit populations of sexual species would offer substantial benefits to humanity and the environment. For example, RNA-guided gene drives could potentially prevent the spread of disease, support agriculture by reversing pesticide and herbicide resistance in insects and weeds, and control damaging invasive species. However, the possibility of unwanted ecological effects and near-certainty of spread across political borders demand careful assessment of each potential application. We call for thoughtful, inclusive, and well-informed public discussions to explore the responsible use of this currently theoretical technology.

Indexed as

CRISPR-Cas SystemsGene Drive TechnologyGene Expression RegulationAnimalsClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Associated ProteinsEvolution, MolecularGene EditingGene Expression Regulation, PlantGenetic Predisposition to DiseaseHumansPlants, Genetically ModifiedRisk AssessmentRNA, Guide, CRISPR-Cas SystemsCRISPR-Associated ProteinsRNA, Guide, CRISPR-Cas Systemscas9chromosomesCRISPRecological engineeringecologyemerging technologygene drivegenesnonepopulation engineering

Identifiers

PMID25035423
PMCPMC4117217
OpenAlexW2144134062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.